PNR vs VNRX · P/E 18, rev $4.18B vs rev $1.4M
Pentair PLC (PNR) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
PNR currently screens at market cap $11.86B and trailing P/E 18.4. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the PNR and VNRX stock pages for the full models.
Not investment advice.